Overview
Chart
Returns
Asset Allocation
Fund Info
Risk & Return Ratio
Fund Overview
  • Rating
    Not Rated
  • Minimum Investment
    ₹500
  • NAV (Net Asset Value)
    ₹N/A
  • AUM (Fund size)
    ₹406 Cr
  • Created on
    5 Dec 2024
Fund Ranking
#
/ 17 in Sectoral-Pharma
Risk Level

Very High

Loading...
Returns
Trailing Return
Rolling Return
  • 6 Month
    25.0%
  • 1 Year
    17.4%
  • 3 Year (CAGR)
    -
  • All Time (CAGR)
    7.1%
Category Return
  • 6 Month
    18.4%
  • 1 Year
    13.5%
  • 3 Year (CAGR)
    20.1%
  • All Time (CAGR)
    16.9%
Asset Allocation
  • Equity
    96.0%
  • Debt
    3.5%
  • Other
    0.6%
Top 5 Holdings
Top 5 Sectors
  • Apollo Hospitals Enterprise
    6.00%
  • Aurobindo Pharma
    6.18%
  • Cipla
    1.39%
  • Dr. Reddy's Laboratories
    1.28%
  • Ipca Laboratories
    2.46%
Fund Information
  • Expense Ratio
    2.59%
  • Exit Load
    1% for redemption within 3 Months
  • Lock-In Period
    No Lock-In

Managed By

Nimesh Chandan
Dec 2024 - Present
Siddharth Chaudhary
Dec 2024 - Present
Vinay Bafna
May 2026 - Present
Bharat Hegde
May 2026 - Present
Sorbh Gupta
Sep 2026 - Present
Risk & Return Ratio
  • Sharpe Ratio
    0.00
  • Standard Deviation
    0.00
  • Alpha
    0.00
  • Beta
    0.00